Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07831239) titled 'Association Between Peripheral Immune Biomarkers and Functional Performance in Multiple Sclerosis' on Sept. 15.

Study Type: Observational

Primary Sponsor: Halic University

Condition: MS (Multiple Sclerosis)

Intervention: Other: Peripheral Immune Biomarkers

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2026

Target Sample Size: 20

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07831239

Published by HT Digital Content Services with permission from Health Daily Digest....